60559-94-6

Basic information

• Product Name: N'-cyano-N-(3-pyridyl)-N''-(t-butyl)guanidine
• Synonyms: N'-cyano-N-(3-pyridyl)-N''-(t-butyl)guanidine;1-tert-Butyl-2-cyano-3-(3-pyridyl)guanidine;CGP-14877;P-1060
• CAS NO: 60559-94-6
• Molecular Formula: C₁₁H₁₅N₅
• Molecular Weight: 217.2703
• Mol File: 60559-94-6.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 332.8°Cat760mmHg
• Flash Point: 155.1°C
• Appearance: /
• Density: 1.08g/cm³
• Vapor Pressure: 0.000142mmHg at 25°C
• Refractive Index: 1.562
• CAS DataBase Reference: N'-cyano-N-(3-pyridyl)-N''-(t-butyl)guanidine(CAS DataBase Reference)
• NIST Chemistry Reference: N'-cyano-N-(3-pyridyl)-N''-(t-butyl)guanidine(60559-94-6)
• EPA Substance Registry System: N'-cyano-N-(3-pyridyl)-N''-(t-butyl)guanidine(60559-94-6)

Safety Data

• Hazardous Substances Data: 60559-94-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H15N5/c1-11(2,3)16-10(14-8-12)15-9-5-4-6-13-7-9/h4-7H,1-3H3,(H2,14,15,16)

Upstream product

• 15268-31-2 3-Pyridyl isocyanate 

Relevant articles and documents

Structure-activity studies of potassium channel opening in pinacidil-type cyanoguanidines, nitroethenediamines, thioureas, and ureas

Potassium channel opening activity for pinacidil-type cyanoguanidines, nitroethenediamines, thioureas, and ureas, has been assessed through simultaneous measurement of spontaneous contractile activity and stimulation of 86Rb+ efflux from rat portal veins loaded with 86Rb+. The good correlation between these two effects suggests that the vasodilator activity of the compounds is directly attributable to an increased opening of potassium channels. The resulting quantitative in vitro data has been used to analyze the structure-activity relationships for potassium channel opening, allowing the biological activity to be rationalized in terms of a pharmacophore involving a hydrogen-bond-acceptor element, a hydrogen-bond- donor element, and a lipophilic binding group. A model for the binding of pinacidil-related compounds to their potassium channel receptor has been developed, and compounds designed to test this model have been synthesized and tested. Prototropic equilibria are implicated as playing a fundamental role in determining the hydrogen-bonding ability of the compounds, and conformational changes in the receptor are invoked to explain disparities in the chiral recognition of lipophilic groups in different compounds.